Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for healthcare industry professionals · Sunday, January 19, 2020 · 507,594,325 Articles · 3+ Million Readers

UNITY Biotechnology, Inc. to Participate in the 2019 Cantor Global Healthcare Conference

/EIN News/ -- SAN FRANCISCO, Sept. 20, 2019 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ:UBX], a biotechnology company developing therapeutics to extend healthspan by slowing, halting or reversing diseases of aging, today announced that members of its senior management team will participate in the upcoming Cantor Global Healthcare Conference.

2019 Cantor Global Healthcare Conference

Date: October 3rd, 2019
Presentation Time: 4:10 p.m. ET
Location: New York, NY

A live audio webcast of the presentation will be available through the Investors & Media section of UNITY’s website. An archived replay will be available for 90 days following the event.

About UNITY

UNITY is developing therapeutics to extend healthspan by slowing, halting or reversing diseases of aging. UNITY's initial focus is on creating senolytic medicines to selectively eliminate senescent cells and thereby treat age-related diseases, such as osteoarthritis, eye diseases and pulmonary diseases. More information is available at www.unitybiotechnology.com or follow us on Twitter.

Investors 
                    Endurance Advisors 
                    Peter Rahmer
                    prahmer@enduranceadvisors.com 
                    
                    Media 
                    Jason Spark
                    jason@canalecomm.com

Primary Logo

Powered by EIN News


EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.

Submit your press release